On the other hand, a more recent trial, which was meant to extend the previous findings in a longer and larger multisite randomized double-blinded clinical trial, could not observe any significant cognitive improvement from the participants diagnosed with amnestic MCI or AD after being treated with intranasal insulin for more than 12 months (NCT01767909). Here, INS is linked to Alzheimer disease.